DV
Dividend Vision

FMED — Fidelity Disruptive Medicine ETF

Fidelity Disruptive Medicine ETF (FMED)

FMED carries a 0.50% expense ratio. Total return is 20.1% over the past 3.2 years, 66.4 points behind SPY at 86.5%. Its deepest 1-year drawdown was 18.3%.

Fidelity Disruptive Medicine ETF invests in equity securities of companies involved in innovative healthcare and medical technologies, targeting firms positioned to disrupt traditional medicine and healthcare delivery. The fund carries a 0.50% expense ratio and currently generates no dividend distributions, making it a growth-focused rather than income-generating strategy. This ETF appeals primarily to investors seeking exposure to emerging healthcare innovation and long-term capital appreciation rather than current dividend income.

FMED key facts

Issuer
Fidelity Investments
Asset type
ETF
Asset class
Equity
Inception date
04/16/2020
Expense ratio
0.50%
Last close
$30.21
AUM
$41,586,080
Average volume
2240.0
Ex-dividend date
12/20/2024
Payment date
12/24/2024
Beta
0.8
P/E ratio
42.6903